Day: May 16, 2022

MONTREAL, May 16, 2022 (GLOBE NEWSWIRE) — Following today’s joint announcement with Nouveau Monde Graphite Inc. (NYSE: NMG) (TSX-V: NOU) titled: “Nouveau Monde and Mason Graphite Announce Strategic Investment and Conditional Option and Joint Venture Agreement on Lac Guéret Project”, Mason Graphite Inc. (“Mason Graphite” or the “Company”) (TSX-V: LLG) (OTCQX: MGPHF) is pleased to provide a corporate update on its subsidiary, Black Swan Graphene Inc. (“Black Swan Graphene”). Highlights include:The completion of the subscription receipt financing pursuant to its listing process (the “RTO Transaction”) with Dragonfly Capital Corp., for gross proceeds of approximately $7.0 million, which was upsized from $5.0 million due to high demand, providing for a pro forma valuation of Mason Graphite’s investment in Black Swan Graphene...

MILWAUKEE, Wis., May 16, 2022 (GLOBE NEWSWIRE) — Douglas Dynamics, Inc. (NYSE: PLOW), North America’s premier manufacturer and upfitter of work truck attachments and equipment, today announced that it will host a virtual investor event on Wednesday, May 25th, 2022, via live webcast.Time: 10:30 a.m. Eastern (Lasting ~45 minutes)   Title: Evolving demand creating opportunities for Work Truck Attachments   Content: Roadmap for organic growth opportunities, and exclusive product video and interviews with truck equipment dealers from the 2022 NTEA Work Truck Show   Format: Brief presentations and videos (~30 minutes), followed by Q&A session (~15 minutes)   Hosts: Bob McCormick, President and Chief Executive Officer  Sarah Lauber, Chief Financial Officer  Mark Van Genderen, President, Commercial...

DURHAM, N.C., May 16, 2022 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, today announced that Dale Sander, Chief Financial Officer, and Heather Prichard, Ph.D., Chief Operating Officer, will deliver a corporate presentation in-person at the H.C. Wainwright Global Investment Conference taking place both virtually and in-person at the Fontainebleau Hotel in Miami, on May 24, 2022, at 10:30 a.m. ET. The webcast will be available for replay for at least 30 days following the presentation at https://investors.humacyte.com/news-events/events-and-presentations. About HumacyteHumacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered...

SAN DIEGO, May 16, 2022 (GLOBE NEWSWIRE) — Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that Sabrina Martucci Johnson, the company’s President and CEO, will participate in a virtual fireside chat during the H.C. Wainwright Global Investment Conference. The conference will be held in-person and virtually from May 23-26, 2022, with in-person participation held at the Fountainebleau Miami Beach Hotel in Miami Beach, Florida. Ms. Johnson’s virtual fireside chat will be available on-demand at https://journey.ct.events/view/2fa53f81-bd7f-404e-ad1b-20ea02738d5b and under “Presentations, Events & Webcasts” in the Investors section of the company’s website at http://ir.darebioscience.com, beginning at 7:00 a.m. Eastern Time on May 24, 2022. Following the conclusion of the...

Glen Rock, N.J., May 16, 2022 (GLOBE NEWSWIRE) — RespireRx Pharmaceuticals Inc. (OTCQB:RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and revolutionary treatments to combat diseases caused by disruption of neuronal signaling, is pleased to announce that scientists associated with the Company have published a manuscript that raises the hope of novel treatments for tinnitus, the perception of sound in the absence of external auditory stimulation. Tinnitus is highly prevalent, with 10-15% of the general population worldwide affected, a statistic that can double in the elderly. The disorder can be markedly debilitating and is associated with and likely causal of anxiety, irritability, depression, sleep loss, social isolation, and suicidal ideation. While there are no treatments that demonstrate...